- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on Aug 23, 2022
B-16438153000706FI-MF-000001479Primary placement in Finland; available across 25 countries total.
| Country | On market since | Until |
|---|---|---|
| FinlandPrimary placement | May 22, 2013 | May 26, 2027 |
| Austria | May 22, 2013 | May 26, 2027 |
| Belgium | May 22, 2013 | May 26, 2027 |
| Cyprus | May 22, 2013 | May 26, 2027 |
| Czechia | May 22, 2013 | May 26, 2027 |
| Germany | May 22, 2013 | May 26, 2027 |
| Estonia | May 22, 2013 | May 26, 2027 |
| EL | May 22, 2013 | May 26, 2027 |
| Spain | May 22, 2013 | May 26, 2027 |
| France | May 22, 2013 | May 26, 2027 |
| Hungary | May 22, 2013 | May 26, 2027 |
| Ireland | May 22, 2013 | May 26, 2027 |
| Italy | May 22, 2013 | May 26, 2027 |
| Liechtenstein | May 22, 2013 | May 26, 2027 |
| Lithuania | May 22, 2013 | May 26, 2027 |
| Luxembourg | May 22, 2013 | May 26, 2027 |
| Latvia | May 22, 2013 | May 26, 2027 |
| Malta | May 22, 2013 | May 26, 2027 |
| Poland | May 22, 2013 | May 26, 2027 |
| Portugal | May 22, 2013 | May 26, 2027 |
| Romania | May 22, 2013 | May 26, 2027 |
| Sweden | May 22, 2013 | May 26, 2027 |
| Slovakia | May 22, 2013 | May 26, 2027 |
| Türkiye | May 22, 2013 | May 26, 2027 |
| XI | May 22, 2013 | May 26, 2027 |
W0102070104SOLUBLE TRANSFERRIN RECEPTORCertificate health across this manufacturer's portfolio.
HX 1070846-1Supplemented